Net loss of Natural Biocon (India) reported to Rs 0.01 crore in the quarter ended June 2026 as against net profit of Rs 0.14 crore during the previous quarter ...

Net Sales at Rs 4,336.00 crore in June 2026 up 10% from Rs. 3,941.90 crore in June 2025. Quarterly Net Profit at Rs. 141.10 ...

Biocon's Net Profit Margin significantly decreased from 9.36 percent in March 2025 to 2.17 percent in March 2026, a decline of 76.81 percent. The P/E ratio has risen sharply to 127.98x in March 2026 ...

On July 29, 2026, Genentech, Inc. (“Genentech”) and Hoffmann-La Roche Inc. filed a complaint in the U.S. District Court for the District of New ...

Net Loss of KMF Builders & Developers reported to Rs 0.14 crore in the quarter ended June 2026 as against net loss of Rs 0.32 crore during the previous quarter ...

Biocon founder Kiran Mazumdar-Shaw has flagged the poor condition of Bengaluru’s Bommasandra-Jigani Link Road, highlighting ...

Namma Metro’s Yellow Line has completed its first year of commercial operations with more than 3.8 crore passengers using the ...

Indian pharmaceutical companies are not rushing to relocate manufacturing to the United States despite former President Donald Trump's renewed threat of tariffs up to 200 per cent on imported generic ...

Aug 08, 2026, 2:03 AM IST Biocon - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation Aug 07, 2026, 4:45 AM IST Biocon - Announcement under Regulation 30 (LODR)-Resignation ...

Discover seven iconic women CEOs who placed India on the global business map through pioneering leadership in technology, finance, retail, and biopharmaceuticals.

This wave of Hatch-Waxman cases comes as patent disputes involving GLP-1 receptor agonists, especially Novo Nordisk's Ozempic ...